• Press Release

Mount Sinai Health System Experts at the 2015 ARVO Research Meeting

  • New York, NY
  • (April 30, 2015)

With more than 50 presentations, New York Eye and Ear Infirmary of Mount Sinai and Mount Sinai Health System faculty are leading scientific contributors at the upcoming annual meeting of the Association of Research and Vision in Ophthalmology (ARVO), May 3 – 7, 2015 in Denver, CO.

ARVO is the world’s largest and most respected eye and vision research organizations. Each spring, the annual meeting draws approximately 10,000 scientists and physicians who present their latest research results to peers.

Presentations from Mount Sinai researchers at the Icahn School of Medicine include new revelations into how macular degeneration impacts patients with AIDS, the increasing resistance of ocular pathogens to conventional antibiotic treatments, the ability to track diabetes progression through the eyes, identification of novel biomarkers for primary open angle glaucoma, and the risk of corneal abrasions during lengthy surgical procedures.

Key abstract presentations from the Mount Sinai Health System include:

Sunday, May 3:

Embargoed: 8:30 am
Antibiotic Resistance Among Ocular Pathogens – Results from the ARMOR Surveillance Study 2013-Present
- Penny Asbell, MD, Professor of Ophthalmology and Director of the Cornea Service and Refractive Surgery Center, The Mount Sinai Hospital

Monday, May 4:

Embargoed: 8:30 am
Prevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome
Douglas Jabs, MD, Professor of Ophthalmology and Medicine and Chairman Emeritus of the Department of Ophthalmology, Icahn School of Medicine at Mount Sinai

Embargoed: 12:00 pm
Impaired Lysosomal and Mitochondrial Function in Exfoliation Glaucoma
Audrey Bernstein, PhD, Assistant Professor of Ophthalmology and Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai
Robert Ritch, MD, Shelley and Steven Einhorn Distinguished Chair, and Surgeon Director and Chief, Glaucoma Services, New York Eye and Ear Infirmary of Mount Sinai

Embargoed: 4:25 pm
Changes Over Time in Retinal Vessels in Patients with Early Diabetes
Richard Rosen, MD, Professor of Ophthalmology, Vice Chair and Director of Ophthalmology Research, New York Eye and Ear Infirmary of Mount Sinai

Tuesday, May 5:

Embargoed: 8:30 am
Corneal Abrasion Following Anesthesia for Non-Ocular Surgical Procedures: A Case-Control Study
Priti Batta, MD, Assistant Professor of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai
Ronald C. Gentile, MD, Professor of Ophthalmology and Director of the Ocular Trauma Service, New York Eye and Ear Infirmary of Mount Sinai

Embargoed: 3:45 pm
Developing Micro-RNAs as Biomarkers for Primary Open Angle Glaucoma
Robert Ritch, MD, Shelley and Steven Einhorn Distinguished Chair, and Surgeon Director and Chief, Glaucoma Services, New York Eye and Ear Infirmary of Mount Sinai

About New York Eye and Ear Infirmary of Mount Sinai

New York Eye and Ear Infirmary of Mount Sinai (NYEE) is one of the world's leading facilities for the diagnosis and treatment of all diseases of the eyes, ears, nose, and throat, as well as related conditions. Founded in 1820 as the nation's first specialty hospital, NYEE manages more than 30,000 surgical cases and 225,000 outpatient visits per year. NYEE is regularly ranked as one of the best hospitals in America for Ophthalmology, according to U.S. News & World Report, and has been awarded Magnet status twice for excellence in nursing care.


About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.